Recently, the negotiation of the National Health Insurance Bureau ended perfectly, and 121 drugs were successfully negotiated or bided, with an average price reduction of 617%。Many men are concerned about the small blue pill (sildenafil-type new domestic generic drugs) in the national centralized procurement also encountered "soul **", once as low as 4 yuan 50mg, compared with the 118 yuan pills that first entered the Chinese market, the dive is serious.
After the release of the results of the ninth batch of national centralized procurement plans, it was finally selected with 89 yuan 50mg ended.
Medical insurance** as the people's "life-saving money", "soul bargaining" can be described as exciting, ** down, but middle-aged men are not very happy, why is this?
1.Under the "soul bargaining", Xiao Lanmaru was pulled off the altar
At the beginning of the 21st century, "sildenafil" entered the Chinese market at 118 yuan per capsule, and the per capita disposable income of domestic families was only 6,860 yuan, and there is no doubt that the market hit a wall. Until the imitation "sildenafil" (Jingo) officially debuted with 60% of the original drug ** and became the head of the series.
Sildenafil is the well-known little blue pill, which was originally developed for cardiovascular disease. "The Paper" once reported that a girl from Zhoukou, Henan Province, who was diagnosed with "pulmonary hypertension", was told that she only had a 2-year lifespan, and if she took the drug**, 1 box would cost nearly 30,000 yuan, and sildenafil was the cheapest drug to effectively control pulmonary hypertension, which was 10 years.
Of course, sildenafil is more well-known for its miraculous effect on men, so it is also nicknamed the "money printing machine" by the market, but the big cake of the market must be coveted by more than one. A number of companies of sildenafil tablets are competing to come out in an attempt to land on the beach, and according to the statistics of the State Food and Drug Administration, 20 have been registered.
In the past, Qilu Pharmaceutical relied on 208 yuan 25mg** became the only winning bidder, the former head became a loser, and the little blue film was downgraded from the high-luxury consumer goods.
A ** battle quietly started ......
At the same time, an emerging male scientific and technological achievement based on aging intervention and long-term maintenance has entered the market, compared with the dual effect of the little blue pill, this achievement called "Yu Liwei" sniped the "unspeakable hidden" more accurately, causing heated discussions.
2.Men's issues should not be turned into a "money game".
Many netizens also expressed concern about the phenomenon of ultra-low-price involution entering centralized procurement: "I am afraid that some companies will use the lower limit standard to enter the market, and finally the bad money will drive out the good money, and the efficacy will be reduced, which is not in line with pharmaceutical economics." ”
In fact, compared with the "soul bargaining" model in previous years, the state has invested more funds to support pharmaceutical innovation this year, and does not emphasize relying on negotiation skills to guide enterprises to win at low prices. According to the statistics of the National Health Insurance Administration, the expenditure on new drugs in the past two years has increased from 594.9 billion yuan increased to 4818.9 billion yuan, a significant increase of 7 times. In addition, the market's encouragement and tolerance of emerging technologies is also expanding, taking the above-mentioned male R&D achievements as an example, in just one year on the shelves, it has topped the relevant list for 11 consecutive days, with a praise rate of 99%.
According to last year's "Blue Book of Healthy China, Happy Era", nearly half of the men in China are plagued by hidden diseases, and Chinese men are affected by traditional concepts, and are always ashamed to speak up and choose to suffer silently for a long time, but with the popularization and in-depth understanding of health knowledge, some men have realized the seriousness of the problem.
According to the data, most of the main people who buy "Yuliwei" come from first-tier or new first-tier cities, mainly white-collar workers and Kochi people, and the age is concentrated in 35-55 years old. Looking at the detail page, it was found that its promotional elements were different from traditional sildenafil products, and it no longer focused on the power of a certain place for men, and focused on maintaining and improving the system under the body, eliminating the drawbacks.
Therefore, despite the high 4-figure figure of this type of product**, it still fights its way out of the encirclement and becomes the new favorite of men. Moreover, as an emerging maintenance technology, "Yuliwei" is not expensive compared with tens of thousands of imported nutritional products.
In the past, sildenafil could not be sold because it was expensive, and now it has fallen to the price of cabbage, but now the market is willing to give new technology opportunities, understanding that the initial research and development cost is higher, and the later cost reduction space is obvious, and the cost performance will be improved!The head of the brand's JD.com said in an interview.
For the majority of patients and people suffering from illness, the "money game" is easy to bring consumption and damage, and quality is still the key to the public's prescription.
3.Every small group will not be abandoned.
The above can see the virtuous circle of national medical insurance policy and market regulation, grasping price reduction with one hand and innovation with the other, and we can feel that we are trying to pay attention to the needs of every patient.
During the negotiations, the negotiator of the National Health Insurance Administration said emotionally: "Every small group should not be abandoned. "It touched the hearts of many people.
The sky-high price of 700,000 yuan for rare disease drugs, nusinersen sodium injection, was reduced to 100,000 yuan at its own expense53,680 yuan of ** was cut to 33,000 yuan a bottle;An original innovative drug for diabetes has also been reduced from 15 yuan to 539 yuan;The hidden disease of men, which was once regarded as an "unspeakable hidden", has received more attention, in addition to the single-digit price reduction of the Xiaolan series, there is also the escort of "Yuliwei".
I hope that in the future, more hidden needs will be discovered and reached, and more life sciences will benefit mankind.